Further information on Fragile X from a company looking for something like a cure

About Fragile X Syndrome

Fragile X Syndrome is the most common inherited form of mental impairment and
the most common known cause of autism. Fragile X Syndrome is caused by a
mutation of a single gene, the Fragile X mental retardation 1 (FMR1) gene, on
the X chromosome. The FMR1 gene produces a protein needed for normal brain
development. Individuals with Fragile X Syndrome lack this protein and, as a
result, exhibit a number of behavioral and physical symptoms including mental
and developmental impairment to varying degrees, attention deficit and
hyperactivity, autistic behaviors, anxiety, large physical attributes,
particularly of the face, and seizures. Fragile X Syndrome typically impacts
boys more severely than girls, with 20% of boys also receiving a diagnosis of
autism. There is no cure for Fragile X Syndrome at this time. A variety of
medications and behavioral interventions are used in an attempt to address
individual symptoms of the disease. Drugs currently used primarily focus on
treating specific symptoms such as anxiety, or improving and controlling
behavior. 

About Seaside Therapeutics

Seaside Therapeutics is creating new drug treatments to correct or improve the
course of Fragile X Syndrome, autism and other disorders of brain development.
We are dedicated to translating breakthrough discoveries in neurobiology into
therapeutics that improve the lives of patients and their families. For more
information visit www.seasidetherapeutics.com.